Australia’s PBS Pays 10 Times Market For Some Drugs, Academic Says
This article was originally published in PharmAsia News
Executive Summary
Australia’s Pharmaceutical Benefits Scheme is paying 10 times the market price in some cases for drugs it subsidizes, according to an academic study.